METASTATIC TRANSITIONAL CELL CARCINOMA

Clinical trials for METASTATIC TRANSITIONAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC TRANSITIONAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill targets genetic weakness in Tough-to-Treat bladder cancers

Disease control Ongoing

This study is testing an oral drug called sapanisertib for people with advanced bladder cancer that has a specific genetic mutation (TSC1 or TSC2) and has stopped responding to standard platinum-based chemotherapy. The goal is to see if the drug can shrink tumors and control the …

Matched conditions: METASTATIC TRANSITIONAL CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

METASTATIC TRANSITIONAL CELL CARCINOMA

Get alerted when new METASTATIC TRANSITIONAL CELL CARCINOMA trials appear

New pill targets genetic weakness in Tough-to-Treat bladder cancers